HPTLC vs DNA Barcoding for Botanical Identity: How Analytical Testing Laboratories Choose the Right Method

The certificate of analysis your botanical supplier sent looks fine. “Identity confirmed” is right there in the summary column. The methodology field says “in-house method.” But if that confirmation came from visual inspection alone — or from a single chromatography run against no external reference standard — you don’t actually know what’s in that drum.

That’s the scenario we encounter regularly when Midwest supplement brands are scaling up and qualifying new ingredient sources. And it’s precisely why two specific methods — HPTLC and DNA barcoding — have become the standard at serious analytical testing laboratories working with botanical raw materials. Both are recognized by the United States Pharmacopeia. Both are legitimate. But they answer fundamentally different questions, and choosing one while assuming it covers everything is where compliance gaps develop.

What HPTLC Actually Measures

High-performance thin-layer chromatography separates a botanical sample’s chemical compounds across a silica gel plate using a solvent system, producing a pattern of spots at distinct retention factors (Rf values). That pattern is the material’s chemical fingerprint.

The real power of HPTLC is comparative analysis. Your sample runs side-by-side against authenticated reference standards — ideally from USP, the American Herbal Pharmacopoeia (AHP), or the CAMAG HPTLC Atlas, which maintains reference chromatograms for hundreds of botanical ingredients. USP currently publishes validated HPTLC procedures for more than 150 botanical ingredients, and the method is explicitly referenced in USP General Chapter <563> for botanical identity testing.

What HPTLC catches reliably: chemical adulteration. If a supplier has spiked ashwagandha powder with a cheaper filler, or substituted a botanically distinct but chemically similar species, the fingerprint pattern shifts in ways a trained analyst can identify. HPTLC also performs well on processed forms — extracts, tinctures, standardized powders — where other methods begin to struggle. Sample volumes can be as small as 1–5 µL, which makes it practical for trace-level work.

The limitation worth understanding: HPTLC reads chemistry, not genetics. If two related species share overlapping phytochemical profiles, the chromatogram alone may not distinguish between them. And for highly processed extracts where heat or solvents have substantially altered the phytochemical matrix, the fingerprint can become ambiguous enough to create false confidence.

Where DNA Barcoding Outperforms Chromatography

DNA barcoding targets specific gene regions in the plant’s genetic material — most commonly the ITS2 (internal transcribed spacer 2) region of nuclear ribosomal DNA, which produces sequences of roughly 200–450 base pairs that are species-specific across most plant families. The sequence obtained from your sample gets compared against validated reference databases to confirm or deny species identity.

The 2013 Newmaster et al. study published in BMC Medicine remains the most widely cited data point on botanical adulteration, and for good reason: 59% of the 44 herbal products tested contained DNA barcodes from plant species not listed on their labels. Substitution was most prevalent in products containing St. John’s Wort, ginkgo, and echinacea. Those findings triggered a wave of regulatory attention — including high-profile state-level investigations — that continues to shape FDA’s enforcement posture on botanical ingredient identity.

DNA barcoding is unambiguous about species. You either have Withania somnifera or you don’t. No amount of chemical similarity between two closely related species will fool a properly executed ITS2 sequence comparison. For species pairs that are genuinely difficult to distinguish by HPTLC — Withania somnifera versus Withania coagulans, Panax ginseng versus Panax quinquefolius, or various Echinacea species — DNA barcoding resolves the question cleanly.

But DNA barcoding requires intact DNA. Once a botanical has been through significant heat processing, solvent extraction at elevated temperatures, or extended milling, the DNA degrades. We’ve analyzed samples from reputable suppliers where the botanical was genuine but the DNA was too fragmented to produce a conclusive barcode sequence. Reporting that as “inconclusive” when the HPTLC fingerprint is a solid match creates unnecessary confusion — and it points to why method selection has to be deliberate, not default.

DNA barcoding is most reliable on: whole herbs, coarsely cut and sifted material, lightly processed powders, and standardized extracts produced below approximately 65°C.

The Cases Where You Need Both

Here’s the practical reality that any experienced analytical testing laboratory will tell you: neither method alone covers every adulteration scenario. That’s why orthogonal testing — running HPTLC and DNA barcoding on the same sample — is increasingly standard in compliance-focused botanical supply chains. And it’s the direction that 21 CFR Part 111 is pushing manufacturers toward, even if the regulation doesn’t prescribe specific methods.

Consider two failure modes that illustrate the gap.

Scenario A: Your supplier ships turmeric (Curcuma longa) powder. DNA barcoding confirms it’s Curcuma longa. The species is correct. But HPTLC shows the curcuminoid fingerprint well below expected ranges, with additional spots suggesting synthetic curcumin or colorant addition. The material is still adulterated — just not at the species level. DNA barcoding alone misses this entirely.

Scenario B: Your supplier ships an ashwagandha extract standardized to 5% withanolides. HPTLC shows a withanolide fingerprint that looks reasonable. But DNA barcoding reveals the material contains Withania coagulans — a related species sometimes substituted as a lower-cost alternative — either blended with or in place of Withania somnifera. HPTLC alone cannot reliably distinguish between these two species’ withanolide profiles, especially in a concentrated extract.

Run both on the same sample and you close both gaps. The incremental cost per sample is real but modest relative to the exposure. A 21 CFR Part 111 warning letter, a market withdrawal, or the kind of FTC scrutiny that’s followed several high-profile botanical supplement cases in recent years makes the per-sample math fairly obvious.

What This Means for Your 21 CFR Part 111 Compliance Posture

Under 21 CFR Part 111.75(a)(1), dietary supplement manufacturers are required to test each incoming component for identity before use. The regulation doesn’t mandate specific methods. But FDA’s guidance on botanical identity testing has been consistent: COA review alone — even from a qualified supplier — doesn’t satisfy the rule’s intent for ingredients with documented adulteration histories.

FDA investigators have issued observations against manufacturers that relied solely on supplier certificates without independent in-house or third-party identity confirmation. The enforcement pattern is most visible in categories where adulteration rates have been extensively documented:

• Ginkgo biloba — frequently adulterated with Sophora japonica leaf, which contains flavonoids that mimic ginkgo’s HPTLC profile
• Echinacea species — substitution between E. purpurea, E. angustifolia, and E. pallida is common
• Milk thistle — silymarin standardization fraud is well-documented in literature
• Valerian — documented adulteration with hops (Humulus lupulus) in multiple published studies

If your ingredient portfolio includes any of these, orthogonal identity testing isn’t a differentiator. It’s what you should already be doing.

For Chicago-area and broader Midwest supplement brands, there’s also a logistics reality that matters. Working with an analytical testing laboratory that has a local sample receiving point eliminates the friction of shipping moisture-sensitive botanical powders and extracts across multiple time zones. Our facility in Countryside, IL receives samples and routes them to ISO 17025–accredited testing infrastructure the same day — with documented chain of custody that holds up in an audit.

Building a Defensible Testing Protocol

The decision framework for choosing methods doesn’t need to be complicated, but it does need to be documented in your SOPs:

• Whole herbs and lightly processed material: lead with DNA barcoding, confirm with HPTLC fingerprinting
• Concentrated extracts and high-temperature powders: lead with HPTLC, add DNA barcoding if processing temperature was confirmed below ~65°C
• Known high-risk botanicals (ginkgo, echinacea, turmeric, ashwagandha, milk thistle): run both methods on every incoming lot regardless of supplier history
• Supplier qualification: run orthogonal testing on the first three lots from any new supplier; consistent clean results provide documented basis for adjusting frequency, but maintain the capability and the SOP to run both on demand

The documentation piece is as important as the testing itself. Your records need to show which method was used, against which reference standard, what the acceptance criteria were, and who performed the analysis. ISO 17025–accredited results come with method validation data and uncertainty estimates that give your compliance records real weight — not just a number on a page.

One more point worth making: your testing protocol should be reviewed whenever your ingredient portfolio changes. A brand that adds four new botanical SKUs in a calendar year without updating its identity testing SOPs has created a gap. Those gaps tend to surface during FDA inspections, not before.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days Contact us

Related from our network

• Botanical Identity and Potency Testing at Qalitex Laboratories — ISO 17025–accredited HPTLC, DNA barcoding, and potency testing for supplement manufacturers across the US